Anti-inflammatory effect of Diammonium Glycyrrhizinate in a rat model of ulcerative colitis

Table 3 DAI, morphologic injury, histological changes, and MPO activity in rats assigned to the different treatment groups

Group	DAI	injury	Morphologic	Histological MPO activity
			changes	(U/g tissue)
DG	3.10 ± 0.54b,d,f	2.80 ± 0.76b,d,f	3.22 ± 0.88b,d,f	0.67 ± 0.06b,d,f
Dexamethasone	1.90 ± 0.43b,d	1.70 ± 0.54b,d	1.76 ± 0.59b,d	0.38 ± 0.05b,d
Acetic acid control	6.70 ± 0.84b	6.30 ± 0.95b	5.96 ± 0.97b	1.32 ± 0.09b
Normal control	0.60 ± 0.38	0.60 ± 0.52	0.74 ± 0.56	0.19 ± 0.05

^bP < 0.01, vs Normal control group; ^dP < 0.01, vs Acetic acid control group; ^fP < 0.01, vs Dexamethasone group.